Phase
Startup
Emulsi Biotech
Nanosystems for oral biologics delivery
Emulsi Biotech AB specializes in lipid-based drug carrier development, with a primary focus on oral biologics delivery. Through our innovative NanoLIPID™ technology platform, we are redefining the delivery of oral biologics. Our technology ensures drug protection from the harsh gastrointestinal environment, while also enabling controlled release and potentially significantly enhancing bioavailability.
Eimantas Gladkauskas is a passionate entrepreneur and innovator with a master’s degree in biotechnology and an ongoing PhD at Lund University. He has extensive experience in lipase applications, natural oil modification, and developing lipid-based solutions. Since founding Emulsi Biotech, Eimantas has transformed a research idea into NanoLIPID™, a cutting-edge platform currently undergoing in vitro and in vivo validation with partners like RISE and private CRO organizations. Alongside this, he runs a successful international marketing consulting business.
Did you know?
New technologies for next-gen antibody therapeutics
Single Molecule Nanowire Biosensors for Diagnostics
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Introducing the fungal based industrial revolution
Automated microscopy image acquisition and analysis
Rapid analyses of human genetic variants
Nanosystems for oral biologics delivery
Fighting iron deficiency
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Digital service for patients
Ultrasound analysis for stroke risk assessment
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
